SPDR S&P Health Care Equipment ETF (XHE)
| Assets | $214.33M |
| Expense Ratio | 0.35% |
| PE Ratio | 32.90 |
| Shares Out | 2.40M |
| Dividend (ttm) | $0.01 |
| Dividend Yield | 0.01% |
| Ex-Dividend Date | Sep 23, 2024 |
| Payout Ratio | 0.26% |
| 1-Year Return | +22.44% |
| Volume | 10,451 |
| Open | 89.46 |
| Previous Close | 89.50 |
| Day's Range | 88.93 - 89.64 |
| 52-Week Low | 73.93 |
| 52-Week High | 93.81 |
| Beta | 0.98 |
| Holdings | 64 |
| Inception Date | Jan 26, 2011 |
About XHE
Fund Home PageThe SPDR S&P Health Care Equipment ETF (XHE) is an exchange-traded fund that mostly invests in health care equity. The fund tracks an equal-weighted index of U.S. health care equipment and supplies companies. XHE was launched on Jan 26, 2011 and is issued by State Street.
Top 10 Holdings
21.91% of assets| Name | Symbol | Weight |
|---|---|---|
| Masimo Corporation | MASI | 2.55% |
| Alphatec Holdings, Inc. | ATEC | 2.40% |
| Integra LifeSciences Holdings Corporation | IART | 2.31% |
| Penumbra, Inc. | PEN | 2.31% |
| AtriCure, Inc. | ATRC | 2.20% |
| Globus Medical, Inc. | GMED | 2.10% |
| Haemonetics Corporation | HAE | 2.08% |
| PROCEPT BioRobotics Corporation | PRCT | 2.00% |
| Insulet Corporation | PODD | 1.99% |
| Inari Medical, Inc. | NARI | 1.97% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Sep 23, 2024 | $0.007 | Sep 25, 2024 |
| Dec 18, 2023 | $0.027 | Dec 21, 2023 |
| Dec 19, 2022 | $0.007 | Dec 22, 2022 |
| Sep 19, 2022 | $0.014 | Sep 22, 2022 |
| Jun 21, 2022 | $0.003 | Jun 24, 2022 |
| Mar 21, 2022 | $0.012 | Mar 24, 2022 |
News
XHE: Could Benefit From Rotation And Catch-Up Against Broader Healthcare
The SPDR S&P Health Care Equipment ETF is a potential investment option for diversifying within the healthcare sector.
XHE: Earnings Surprise Edge, Do The Health Care Quants Have It Wrong?
Seeking Alpha's Quant System downgraded the SPDR S&P Health Care Equipment ETF from Hold to Sell in July. What followed was a 21% decline, 18% worse than the broader sector. An evaluation of XHE's Rat...
XHE: We Expect Consistent Double-Digit Returns For The Foreseeable Future
The Healthcare equipment industry has been a consistently well-performing industry in the last decade, and there is little evidence of this slowing down. SPDR® S&P Health Care Equipment ETF used to ge...
XHE: Health Care Equipment Stocks Are Overvalued On Low Quality Earnings
XHE invests in health care equipment stocks. Unfortunately, in order to arrive at a decent implied IRR, one must ignore the fund's poor quality portfolio earnings.
SPDR S&P Health Care Equipment ETF Remains Overvalued Despite Recent Declines
XHE is currently rebounding from recent lows, but based on its present valuation, I think it makes sense that further downside is in store. While all equity funds tend to correlate with the major and ...
XHE: I Expect The Double-Digit Growth To Continue
Medical devices, healthcare equipment and healthcare supplies grew during the pandemic and the sector is expected to grow further.
XHE: An ETF For The 2020s And Beyond
XHE is a $679 million fund with a passive investment strategy tracking the modified equal-weighted S&P Health Care Equipment Select Industry Index. XHE has grossly outperformed the S&P 500 since incep...
SPDR S&P Health Care Equipment ETF Provides Targeted Sectoral Performance For Diversified Portfolios
SPDR S&P Health Care Equipment is a targeted ETF specializing in healthcare segment. The fund achieves diversification by investing in a large number of companies with varied M-Caps.
SPDR S&P Health Care Equipment ETF: Why Consistent, Double-Digit Returns Should Continue
The S&P Health Care Equipment ETF has been a consistent performer since its inception in 2011, beating out both the S&P 500 and the broader Health Care sector. Increases in U.S. spending on durable me...
Best And Worst Q4 2020: Healthcare ETFs And Mutual Funds
The Healthcare sector ranks eighth in Q4'20. Based on an aggregation of ratings of the 359 stocks in the Healthcare sector.
Health Care Services and Equipment Stocks Poised for Gains
While most attention in health care has been going to large pharma companies, the charts suggest opportunities in niche subsectors.
Biotech stocks fall after Trump promises executive order drug prices
CNBC's Meg Tirrell reports on the dip in biotech stocks after President Donald Trump promised that an executive order on drug prices is coming.
Watch a CIO explain where investors can find value in the market amid trade tensions
Chris Zaccarelli, chief investment officer at Independent Advisor Alliance, joins "Squawk Box" to discuss where investors can find value in the markets as they continue to digest the news surrounding ...